Cite
Poordad F, Lawitz E, Gutierrez JA, et al. An HCV-positive recipient of an HCV-positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin. Clin Case Rep. 2017;5(4):371-375doi: 10.1002/ccr3.841.
Poordad, F., Lawitz, E., Gutierrez, J. A., Guerrero, J., Speeg, K., & Swenson, E. S. (2017). An HCV-positive recipient of an HCV-positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin. Clinical case reports, 5(4), 371-375. https://doi.org/10.1002/ccr3.841
Poordad, Fred, et al. "An HCV-positive recipient of an HCV-positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin." Clinical case reports vol. 5,4 (2017): 371-375. doi: https://doi.org/10.1002/ccr3.841
Poordad F, Lawitz E, Gutierrez JA, Guerrero J, Speeg K, Swenson ES. An HCV-positive recipient of an HCV-positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin. Clin Case Rep. 2017 Feb 03;5(4):371-375. doi: 10.1002/ccr3.841. eCollection 2017 Apr. PMID: 28396749; PMCID: PMC5378822.
Copy
Download .nbib